These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 21904950)
1. Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies. Wu Q; Bencaz AF; Hentz JG; Crowell MD Osteoporos Int; 2012 Jan; 23(1):365-75. PubMed ID: 21904950 [TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis. Khanassov V; Hu J; Reeves D; van Marwijk H Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774 [TBL] [Abstract][Full Text] [Related]
3. Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies. Wu Q; Qu W; Crowell MD; Hentz JG; Frey KA J Bone Miner Res; 2013 Apr; 28(4):753-63. PubMed ID: 23165455 [TBL] [Abstract][Full Text] [Related]
4. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older. Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Moura C; Bernatsky S; Abrahamowicz M; Papaioannou A; Bessette L; Adachi J; Goltzman D; Prior J; Kreiger N; Towheed T; Leslie WD; Kaiser S; Ioannidis G; Pickard L; Fraser LA; Rahme E Osteoporos Int; 2014 May; 25(5):1473-81. PubMed ID: 24566587 [TBL] [Abstract][Full Text] [Related]
6. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis. Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621 [TBL] [Abstract][Full Text] [Related]
7. Relationship between use of antidepressants and risk of fractures: a meta-analysis. Rabenda V; Nicolet D; Beaudart C; Bruyère O; Reginster JY Osteoporos Int; 2013 Jan; 24(1):121-37. PubMed ID: 22638709 [TBL] [Abstract][Full Text] [Related]
8. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. Eom CS; Lee HK; Ye S; Park SM; Cho KH J Bone Miner Res; 2012 May; 27(5):1186-95. PubMed ID: 22258738 [TBL] [Abstract][Full Text] [Related]
9. Osteoporosis and Fracture Risk Associated with Novel Antidepressants: A Systematic Review and Meta-Analysis. Hu J; Xie K; Wu S; Chen Y Actas Esp Psiquiatr; 2024 Jun; 52(3):334-346. PubMed ID: 38863057 [TBL] [Abstract][Full Text] [Related]
10. Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study. Wang CY; Fu SH; Wang CL; Chen PJ; Wu FL; Hsiao FY Osteoporos Int; 2016 Jan; 27(1):57-63. PubMed ID: 26126579 [TBL] [Abstract][Full Text] [Related]
11. Association between use of benzodiazepines and risk of fractures: a meta-analysis. Xing D; Ma XL; Ma JX; Wang J; Yang Y; Chen Y Osteoporos Int; 2014 Jan; 25(1):105-20. PubMed ID: 24013517 [TBL] [Abstract][Full Text] [Related]
12. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Richards JB; Papaioannou A; Adachi JD; Joseph L; Whitson HE; Prior JC; Goltzman D; Arch Intern Med; 2007 Jan; 167(2):188-94. PubMed ID: 17242321 [TBL] [Abstract][Full Text] [Related]
13. Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Verdel BM; Souverein PC; Egberts TC; van Staa TP; Leufkens HG; de Vries F Bone; 2010 Sep; 47(3):604-9. PubMed ID: 20601295 [TBL] [Abstract][Full Text] [Related]
14. Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis. Kumar M; Bajpai R; Shaik AR; Srivastava S; Vohora D Eur J Clin Pharmacol; 2020 Oct; 76(10):1373-1392. PubMed ID: 32556910 [TBL] [Abstract][Full Text] [Related]
15. Antidepressant medications in women aged 40 and older and the risk of fragility fractures: a systematic literature review and meta-analysis. Alsugeir D; John M; Tillyer E; Wei L; Brauer R Expert Opin Pharmacother; 2024 Oct; 25(14):1961-1970. PubMed ID: 39329177 [TBL] [Abstract][Full Text] [Related]
17. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM; Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097 [TBL] [Abstract][Full Text] [Related]
18. Risk of Fractures With Concomitant Use of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors. Desai R; Smith SM; Mohandas R; Brown J; Park H Ann Pharmacother; 2024 Sep; 58(9):886-895. PubMed ID: 38078408 [TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268 [TBL] [Abstract][Full Text] [Related]
20. Bones of Contention: A Comprehensive Literature Review of Non-SSRI Antidepressant Use and Bone Health. Power C; Duffy R; Mahon J; McCarroll K; Lawlor BA J Geriatr Psychiatry Neurol; 2020 Nov; 33(6):340-352. PubMed ID: 31665962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]